癌的分子代码:基因突变和精确治疗的发现之路
Deqian Xie1, Guandu Li1, Zunwen Zheng1
1Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116011, China.
Molecular aspects of medicine
|January 2, 2025
概括
本综述详细介绍了细胞癌 (RCC) 中常见的基因突变,强调它们在瘤发育和进展中的作用. 它探讨了针对性疗法,包括代谢和免疫策略,用于个性化RCC治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 细胞癌 (RCC) 表现出复杂的分子异质性.
- 关键的突变基因 (VHL,PBRM1,BAP1,SETD2) 影响关键的细胞过程.
- 这种PI3K/AKT/mTOR通路在RCC的发病过程中至关重要.
研究的目的:
- 系统地分析RCC中的遗传突变.
- 为了阐明驱动RCC的分子机制.
- 探索RCC的新型治疗策略.
主要方法:
- 对TCGA和COSMIC数据库进行系统分析.
- 在RCC中鉴定了24个关键突变基因.
- 审查当前和新兴的治疗方法.
主要成果:
- 鉴定了影响信号传递,染色体和DNA修复的VHL,PBRM1,BAP1,SETD2突变.
- 相关的PI3K/AKT/mTOR路径突变 (PIK3CA,MTOR,PTEN) 与代谢异常和增殖有关.
- 突出了mTOR抑制剂,VEGF向药物的有效性,以及GLS1抑制剂的潜在作用.
结论:
- 基因突变显著影响RCC的诊断,治疗和预后.
- 多途径向治疗,代谢向,免疫治疗和纳米技术提供了有前途的途径.
- 对于特定的RCC亚型来说,个性化治疗策略至关重要.
关键词:
基因突变是一种基因突变.在 HIF 信号通道上.免疫微环境是一个微环境.免疫治疗是一种免疫疗法.代谢重编程是一种代谢重编程.在PI3K/AKT/mTOR路径中.细胞癌是细胞癌.有针对性的治疗.更多相关视频
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


